Clinical Trial Update: APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cardiac resynchronization therapy in patients with permanent atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Drugs mentioned

• Cardiac resynchronization therapy

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Congestive Heart Failure, Atrial Fibrillation | Phase 3 | Status: COMPLETED